[HTML][HTML] Leukocyte-endothelial cell adhesion: avenues for therapeutic intervention

J Panés, M Perry, DN Granger - British journal of pharmacology, 1999 - ncbi.nlm.nih.gov
J Panés, M Perry, DN Granger
British journal of pharmacology, 1999ncbi.nlm.nih.gov
Abbreviations: AP-1, activation protein-1; CAM, cell adhesion molecule; ESL, E-selectin
ligand; ICAM, intercellular adhesion molecule; IL, interleukin; mAb, monoclonal antibody; NF-
kB, nuclear factor kappa-B; MAdCAM, mucosal address in cell adhesion molecule; ODN
oligodeoxynucleotide; PSGL-1, P-selectin glycoprotein ligand-1; PSL, P-selectin ligand;
PECAM, platelet endothelial cell adhesion molecule; TFD, transcription factor decoy; TNF-a,
tumour necrosis factor-alpha; VCAM, vascular cell adhesion molecule; VLA, very late …
Abbreviations: AP-1, activation protein-1; CAM, cell adhesion molecule; ESL, E-selectin ligand; ICAM, intercellular adhesion molecule; IL, interleukin; mAb, monoclonal antibody; NF-kB, nuclear factor kappa-B; MAdCAM, mucosal address in cell adhesion molecule; ODN oligodeoxynucleotide; PSGL-1, P-selectin glycoprotein ligand-1; PSL, P-selectin ligand; PECAM, platelet endothelial cell adhesion molecule; TFD, transcription factor decoy; TNF-a, tumour necrosis factor-alpha; VCAM, vascular cell adhesion molecule; VLA, very late antigens
ncbi.nlm.nih.gov